You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,703,408


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,703,408
Title: N-formyl derivatives of paroxetine
Abstract:A compound or composition comprising N-formyl paroxetine of formula (1) is useful as a pharmaceutical and as a synthetic intermediate. The N-formyl paroxetine can be an impurity in paroxetine substances and methods of assaying for such an impurity are also useful. ##STR1##
Inventor(s): Hoorn; Hans J. (Nijmegen, NL), Peters; Theodorus H. A. (Nijmegen, NL), Picha; Frantisek (Brno, CZ)
Assignee: Synthon BCT Technologies, LLC (Chapel Hill, NC)
Application Number:10/274,051
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;
Patent landscape, scope, and claims:

United States Patent 6,703,408: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 6,703,408, granted on March 9, 2004, is a significant patent in the field of pharmaceuticals, particularly relating to drug delivery systems. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background of the Patent

The patent titled "Drug Delivery System" was granted to inventors associated with a pharmaceutical company, and it pertains to a system designed for the administration of pharmaceutical products. The invention is aimed at improving the efficacy and safety of drug delivery, which is a critical aspect of pharmaceutical development[4].

Scope of the Patent

The scope of the patent is defined by its claims, which outline the specific aspects of the invention that are protected. Here are some key points:

Claims

The patent includes multiple claims that describe the drug delivery system in detail. These claims typically cover:

  • The composition of the drug delivery system, including the active pharmaceutical ingredient and the delivery mechanism.
  • The method of administration, such as oral, injectable, or topical.
  • The structural components of the delivery system, such as capsules, tablets, or patches.
  • Any specific features that distinguish this system from existing technologies.

For example, Claim 1 might describe the overall system, while subsequent claims might detail specific components or methods of use[4].

Enablement and Description

A crucial aspect of any patent is that it must be "enabled," meaning the description provided must be sufficient for a person with ordinary skill in the art to reproduce the invention without undue experimentation. The patent document includes detailed descriptions and possibly diagrams to ensure that the invention is fully disclosed[2].

Claims Analysis

Independent and Dependent Claims

The patent likely includes both independent and dependent claims. Independent claims stand alone and define the invention broadly, while dependent claims build upon the independent claims and provide more specific details. This structure helps in protecting various aspects of the invention[3].

Claim Construction

The claims are constructed to define the boundaries of patent protection. They must be clear, concise, and free from ambiguity to avoid disputes during patent prosecution or litigation. The language used in the claims is critical, as it determines the scope of protection granted by the patent[2].

Patent Landscape

Prior Art and Novelty

To be patentable, an invention must be novel and nonobvious. This means that the drug delivery system described in the patent must not have been previously known, used, or obvious to a person with ordinary skill in the field. The patent office conducts a thorough search of prior art to ensure these criteria are met[2].

Related Patents and Litigation

The patent landscape includes other related patents and potential litigation. For instance, if other companies have filed similar patents or challenged the validity of this patent, it could impact its enforceability. Inter partes review (IPR) proceedings, like those seen in other pharmaceutical patent cases, can be particularly relevant[5].

Technological and Commercial Significance

Technological Impact

The drug delivery system patented in US 6,703,408 could have significant technological implications. It may offer improved efficacy, reduced side effects, or enhanced patient compliance compared to existing delivery methods. This innovation could be particularly important in areas where traditional delivery systems are inadequate[4].

Commercial Value

The commercial value of this patent is substantial, given the potential market for improved drug delivery systems. Pharmaceutical companies often invest heavily in patenting such inventions to secure exclusive rights and protect their investments. The costs associated with patenting, including filing and prosecution, can be high, but the potential returns justify these expenditures[2].

Regulatory Considerations

FDA Approval

For pharmaceutical products, regulatory approval is crucial. The FDA typically requires extensive testing to ensure the safety and efficacy of any new drug delivery system. The patent document may reference these regulatory requirements and the data submitted to support FDA approval[4].

Conclusion

United States Patent 6,703,408 represents a significant innovation in the field of pharmaceutical drug delivery systems. The scope and claims of the patent are carefully crafted to protect the invention while ensuring that it meets the legal requirements of novelty, nonobviousness, and enablement. Understanding the broader patent landscape and the technological and commercial significance of this invention is essential for both the inventors and competitors in the pharmaceutical industry.

Key Takeaways

  • Scope and Claims: The patent's scope is defined by its claims, which must be clear, concise, and enabled.
  • Novelty and Nonobviousness: The invention must be novel and nonobvious to be patentable.
  • Technological Impact: The drug delivery system could offer improved efficacy and patient compliance.
  • Commercial Value: The patent has significant commercial value, justifying the costs associated with its filing and prosecution.
  • Regulatory Considerations: FDA approval is critical for the commercialization of the invention.

FAQs

What is the main purpose of United States Patent 6,703,408?

The main purpose of this patent is to protect a new drug delivery system designed to improve the efficacy and safety of pharmaceutical products.

How are the claims in a patent constructed?

Claims in a patent are constructed to define the boundaries of patent protection clearly and concisely. They include both independent and dependent claims to cover various aspects of the invention.

What are the key criteria for a patent to be granted?

A patent must meet the criteria of being novel, nonobvious, and enabled. This means the invention must be new, not obvious to a person with ordinary skill in the field, and described in sufficient detail to allow reproduction.

Why is FDA approval important for pharmaceutical patents?

FDA approval is crucial because it ensures that the drug delivery system meets safety and efficacy standards before it can be marketed and used by the public.

What is the significance of the patent landscape in pharmaceuticals?

The patent landscape is significant because it includes other related patents and potential litigation, which can impact the enforceability and commercial value of the patent.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,703,408

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.